Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
21
2
4
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 21 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community
Role: lead
Cognitive Remote Assessment Using FLAME (CRA-FLAME)
Role: lead
β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline
Role: lead
Early Identification of Markers in Alzheimer's Families / ALFA
Role: lead
Characterization of Cerebral Tau Aggregates With 18F-RO6958948 PET in the ALFA Population
Role: lead
Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants
Role: lead
Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.
Role: lead
ALFAsleep: Exploring Cognitive and Biological Correlates of Sleep Quality and Their Potential Links With Alzheimer's Disease
Role: lead
Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention
Role: collaborator
Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging
Role: lead
Comparison of Magnetic Resonance Techniques for the Measurement of Cerebral Blood Perfusion
Role: lead
BarcelonaBeta Dementia Prevention Research Clinic: a Study on Risk Factors Disclosure
Role: lead
Recovery of Biographical Memories Associated With a Melody: a Functional Magnetic Resonance Imaging Study
Role: lead
Study for Cognitive and Genetic Characterization of a 45-65 Years Old Population
Role: lead
Cross-sectional Study for the Identification of Blood Biomarkers in Healthy Young and Old Individuals
Role: lead
Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease (NPAD)
Role: lead
Control and Intervention Programme on Alzheimer's Disease Risk Factors
Role: lead
Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old
Role: lead
Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres
Role: lead
Experimental Study to Validate the "Therapeutic Game" CONEM-BETA
Role: lead